Barinthus Biotherapeutics plc (BRNS) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Following the restructuring, Barinthus Biotherapeutics has focused on strict liquidity preservation and conducting independent trials. This chart of current share prices with the 0.00 metric links this stage to the development of university partnerships to bring T-cell therapies to market. Simultaneously, the business is implementing energy-saving technologies and purification systems in its laboratories to minimize environmental impact.
Barinthus Biotherapeutics plc - analytical breakdowns and key metrics (BRNS)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
Debt to Equity Barinthus Biotherapeutics|BRNS - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital barinthusbio.com|BRNS - Company Cumulative Debt|Debts to Book Capitalization Barinthus Biotherapeutics plc|BRNS - Company Long-Term Debt|Company Short-Term Debts Barinthus Biotherapeutics|Quick Liquidity barinthusbio.com
- business earnings and investment ratios data:
BRNS - Final Profit|Projected Future Earnings Barinthus Biotherapeutics|BRNS - Business Payback Period|Future Price to Earnings Barinthus Bio|BRNS - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio Barinthus Biotherapeutics Corp|BRNS - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Barinthus Biotherapeutics|BRNS - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months barinthusbio.com|BRNS - Earnings growth in current year|Net earnings per share growth forecast for next year Barinthus Biotherapeutics
- sales and revenue data:
Initial company analysis:Barinthus Biotherapeutics BRNS
Investments in the high-tech sector require strict control of debt loads, which is why the EV/EBITDA ratio of Barinthus Biotherapeutics (BRNS) allows for an assessment of the total business value relative to its operating efficiency, excluding taxes and interest. Analysis of this chart helps determine whether the robotic systems and AI algorithms of Barinthus Biotherapeutics are capable of generating sufficient cash flow to service obligations and ensure financial stability.
Who Barinthus Biotherapeutics competes with
EV/EBITDA Multiple ARGX (argenx.com)|Total Company Value to Operating Income Before Depreciation Ratio biontech.de (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ADMA Biologics Inc (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist Corp (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant, Inc.|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple grifols.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies Corp (ADPT)|Celldex Therapeutics, Inc. - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (auriniapharma.com)|BioCryst Pharmaceuticals Inc (BCRX) - Company Value to EBITDA|VERA: Enterprise Value to EBITDA Ratio|DNTH (Dianthus Therapeutics) - Enterprise Value to Operating Income Before Depreciation|PHVS: EV/EBITDA Multiple|ABCL (AbCellera Biologics Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio TRML|Company Value to EBITDA Intrexon PGEN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming Group N.V. (PHAR)|Enterprise Value to Operating Income Before Depreciation Ratio NKTR|EV/EBITDA Multiple UPB (Upstream Pharma)|Total Company Value to Operating Income Before Depreciation Ratio Zenas Biopharma, Inc. (ZBIO)|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Gossamer Corp (GOSS) - Enterprise Value to EBITDA Ratio|KALV (KalVista Pharmaceuticals Inc) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation SEPN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pieris Pharmaceuticals|Savara Inc (SVRA) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RIGL|Total Company Value to Operating Income Before Depreciation Ratio AnaptysBio Inc.|EV/EBITDA Multiple ATXS (Astria Therapeutics Inc)|enGene Holdings Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|RAPT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation JBIO (aerovatetx.com)|Aclaris (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Kyverna - Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio TLSA|Company Value to EBITDA Cabaletta Bio CABA|EV/EBITDA Multiple VTYX|Theratechnologies (THTX) - Enterprise Value to EBITDA Multiple|Avalo Therapeutics - Enterprise Value to EBITDA Ratio|Eledon Pharmaceuticals (ELDN) - Company Value to EBITDA|Agenus, Inc - EV/EBITDA Multiple|Company Value to EBITDA climbbio.com|ZURA (Zura Bio Limited) - Enterprise Value to EBITDA Ratio|aTyr (ATYR) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio ADAG|IMA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Shattuck Therapeutics (STTK)|Enterprise Value to EBITDA Ratio Equillium EQ|Connect Biopharma Holdings Limited - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation IMUX|ATRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|inflarx.de (IFRX) - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation X4 Pharmaceuticals XFOR|ACET - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization celularity.com|INMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple KZR|SABS: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AKTX (Akari Therapeutics, Plc)|ENLV (Enlivex Therapeutics, Ltd.) - Company Value to Operating Income Before Depreciation Ratio|QTTB: Enterprise Value to EBITDA Ratio|GOVX - EV/EBITDA Multiple|Edesa Biotech Corp (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IBIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization carismatx.com|XTLB: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics Inc. (BOLT)|HCWB (HCW Biologics) - Business Value to Operating Income Before Depreciation|Aptevo Therapeutics - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple AIM ImmunoTech Inc. AIM|Aditxt Inc. - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation GRI (GRI Bio, Inc.)|XORTX Therapeutics Inc (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ReShape Lifesciences|Enterprise Value to EBITDA Ratio REVB|Indaptus Corp (INDP) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization scinai.com (SCNI)|Enterprise Value to EBITDA Ratio CalciMedica CALI|EV/EBITDA Multiple AFMD (affimed.com)|Allakos Inc. (ALLK) - Company Value to EBITDA|HOOKIPA - EV/EBITDA Multiple|IGMS (igmbio.com) - Enterprise Value to Operating Income Before Depreciation|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation OCEA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC BioPharm|Third Harmonic Bio Inc. (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
